TRAF6 regulates proliferation and differentiation of skeletal myoblasts

Differentiation

Volumn 81, Issue 2, 2011, Pages 99-106

  Mueck, Tobias ^a   Berger, Felicitas ^a   Buechsler, Ingrid ^a   Valchanova, Ralitsa S ^a   Landuzzi, Lorena ^b   Lollini, Pier Luigi ^c   Klingel, Karin ^d   Munz, Barbara ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Myogenic differentiation; Rhabdomyosarcoma; TRAF6

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; IN VITRO STUDY; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHABDOMYOSARCOMA; SKELETAL MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; MICE; MUSCLE DEVELOPMENT; MUSCLE NEOPLASMS; MYOBLASTS, SKELETAL; NF-KAPPA B; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; REGENERATION; RHABDOMYOSARCOMA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 79551687102     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2010.11.002     Document Type: Article

References (39)

1. Arch R.H., Gedrich R.W., Thompson L.B. Tumor necrosis factor receptor-associated factors (TRAFs)-a family of adapter proteins that regulates life and death. Genes Dev. 1998, 12:2821-2830.
2. Astolfi A., De Giovanni C., Landuzzi L., Nicoletti G., Ricci C., Croci S., Scopece L., Nanni P., Lollini P.L. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene 2001, 274:139-149.
3. Baeza-Raja B., Muňoz-Cánoves P. p38 MAPK-induced nuclear factor-kappa B activity is required for skeletal muscle differentiation: role of interleukin-6. Mol. Biol. Cell 2004, 15:2013-2026.
4. Bakkar N., Wang J., Ladner K.J., Wang H., Dahlman J.M., Carathers M., Acharyya S., Rudnicki M.A., Hollenbach A.D., Guttridge D.C. IKK/NF-kappa B regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 2008, 180:787-802.
5. Bradley J.R., Pober J.S. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 2001, 20:6482-6491.
6. Chung J.Y., Park Y.L., Ye H., Wu H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 2002, 115:679-688.
7. Chung J.Y., Lu M., Yin Q., Lin S.C., Wu H. Molecular basis for the unique specificity of TRAF6. Adv. Exp. Mol. Biol. 2007, 597:122-130.
8. Dahlman J.M., Wang J., Bakkar N., Guttridge D.C. The RelA/p65 subunit of NF-kappa B specifically regulated cyclin D1 protein stability: implications for cell cycle withdrawal and skeletal myogenesis. J. Cell. Biochem. 2009, 166:42-51.
9. Ehlers S., Mueck T., Adams S., Landuzzi L., Lollini P.-L., Munz B. RIP2 regulates growth and differentiation of normal myoblasts and of rhabdomyosarcoma cells. Eur. J. Cell Biol. 2008, 87:31-38.
10. Endesfelder S., Krahn A., Kreuzer K.A., Lass U., Schmidt C.A., Jahrmarkt C., von Moers A., Speer A. Elevated p21 mRNA level in skeletal muscle of DMD patients and mdx mice indicates either an exhausted satellite cell pool or a higher p21 expression in dystrophin-deficient cells per se. J. Mol. Med. 2000, 78:569-574.
11. Florini J.R., Ewton D.Z., Coolican S.A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 1996, 17:481-517.
12. Funakoshi-Tago M., Kamada N., Shimizu T., Hashiguchi Y., Tago K., Sonoda Y., Kashahara T. TRAF6 negatively regulates TNF alpha-induced NF-kappa B activation. Cytokine 2009, 45:72-79.
13. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., Baldwin A.S. NF-kappa B controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 1999, 19:5785-5799.
14. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., Baldwin A.S. NF-kappa-B-induced loss of Myo D messenger RNA: possible role in muscle decay and cachexia. Science 2000, 289:2363-2366.
15. Inoue J., Ishida T., Tsukamoto N., Kobayashi N., Naito A., Azuma S., Yamamoto T. Tumor necrosis factor receptor-associated factor (TRAF) family:adapter proteins that mediate cytokine signaling. Exp. Cell Res. 2000, 254:14-24.
16. Inoue J., Gohda J., Akiyama T. Characteristics and biological functions of TRAF6. Adv. Exp. Med. Biol. 2007, 597:72-79.
17. Keren A., Tamir Y., Bengal E. The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol. 2006, 252:224-230.
18. Kobayashi T., Walsh M.C., Choi Y. The role of TRAF6 in signal transduction and the immune response. Microbes Infect. 2004, 6:1333-1338.
19. Lee N.K., Lee S.Y. Modulation of life and death by the tumor necrosis factor receptor-associated factors (TRAFs). J. Biochem. Mol. Biol. 2002, 35:61-66.
20. Li Y.P., Schwartz R.J. TNF-alpha regulates early differentiation of C2C12 myoblasts in an autocrine fashion. FASEB J. 2001, 15:1413-1415.
21. Lollini P.L., De Giovanni C., Landuzzi L., Nicoletti G., Scotlandi K., Nanni P. Reduced metastatic ability of in vitro differentiated human rhabdomyosarcome cells. Invasion Metastasis 1991, 11:118-124.
22. Lollini P.L., Landuzzi L., Frabetti F., Rossi I., Nicoletti G., Scotlandi K., Serra M., Galdini N., DeGiovanni C., Nanni P. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells. Clin. Cancer Res. 1998, 4:1843-1849.
23. Lomaga M.A., Yeh W.-C., Sarosi I., et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1. CD40, and LPS signaling. Genes Dev. 1999, 13:1015-1024.
24. Moynagh P.N. The NF-κB pathway. J. Cell Sci. 2005, 118:4389-4392.
25. Munz B., Wiedmann M., Lochmüller H., Werner S. Cloning of novel injury-regulated genes. Implications for an important role of the muscle-specific protein skNAC in muscle repair. J. Biol. Chem. 1999, 274:13305-13310.
26. Munz B., Hildt E., Springer M.L., Blau H.M. RIP2, a checkpoint in myogenic differentiation. Mol. Cell. Biol. 2002, 22:5879-5886.
27. Naito A., Azuma S., Tanaka S., et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999, 4:353-362.
28. Naito A., Yoshida H., Nishioka E., Satoh M., Azuma S., Yamamoto T., Nishikawa S.-i., Inoue J.-i. TRAF6-deficient mice display hypohidriotic ectodermal dysplasia. Proc. Natl. Acad. Sci. USA 2002, 99:8766-8771.
29. Oliver L., Raulais D., Vigny M. Acidic fibroblast growth factor (aFGF) in developing normal and dystrophic (mdx) mouse muscles. Distribution in degenerating and regenerating mdx myofibres. Growth Factors 1992, 7:97-106.
30. Perdiguero E., Ruiz-Bonilla V., Serrano A.L., Muňoz-Cánoves P. Genetic deficiency of p38 alpha reveals its critical role in myoblast cell cycle exit: the p38-JNK connection. Cell Cycle 2007, 6:1298-1303.
31. Snider L., Tapscott S.J. Emerging parallels in the generation and regeneration of skeletal muscle. Cell 2003, 113:811-812.
32. Thomas R. The TRAF6-NF kappa B signaling pathway in autoimmunity: not just inflammation. Arthritis Res. Ther. 2005, 7:170-173.
33. Tkatchenko A.V., LeCam G., Léger J.J., Dechesne C.A. Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse. Biochim. Biophys. Acta 2000, 1500:17-30.
34. Wang H., Garzon R., Sun H., Ladner K.J., Singh R., Dahlman J., Cheng A., Hall B.M., Qualman S.J., Chandler D.S., Croce C.M., Guttridge D.C. NF kappa B-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008, 14:369-381.
35. Wu H., Arron J.R. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity, and osteoimmunology. Bioessays 2003, 25:1096-1105.
36. Xia S.J., Pressey J.G., Barr F.G. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol. Ther. 2002, 1:97-104.
37. Yamashita M., Fatyol K., Jin C., Wang X., Liu Z., Zhang Y.E. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol. Cell 2008, 31:918-924.
38. Yang H., Landis-Piwowar K.R., Chen D., Milacic V., Dou Q.P. Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Curr. Protein Pept. Sci. 2008, 9:227-239.
39. Yotov W.V., St.-Arnaud R. Differential splicing-in of a proline-rich exon converts alphaNAC into a muscle-specific transcription factor. Genes Dev. 1996, 10:1763-1772.